Related Experiment Video
Updated: Mar 3, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway
Yang Chen1,2,3, Yun Hu1,2,3, Lan Yang1,2,3
1College of Stomatology, Chongqing Medical University, Chongqing, 401147, China.
Abstract:
Hyperglycemia is one of the most important pathogenesis of diabetic osteopathy. Several lines of studies indicate Runx2 plays a critical role in the process of osteogenic differentiation. However, little studies have analyzed the effect of Runx2 on osteoblast differentiation of rat bone mesenchymal stem cells (rBMSCs) in high-glucose condition. In this study, the effect of Runx2 on osteoblast differentiation in high-glucose condition was evaluated by the expression of osteogenesis-related maker including Runx2, ALP, OC, and OPN, as well as ALP staining, ALP activity, and Alizarin red S staining. Western blot analysis was performed to detect the protein expression levels of p-AKT, AKT, p-GSK3β, GSK3β, and β-catenin. Immunofluorescence staining analysis was performed to detect subcellular localization of β-catenin. Our results revealed that high glucose significantly inhibited osteogenic differentiation, hyperosmolarity did not cause a suppression. In addition, Runx2 could upregulate the expression of osteogenic-related genes and increase matrix mineralization, while applying 10 µM PI3K/AKT inhibitor LY294002 abolished the beneficial effect. Collectively, these results indicate that Runx2 alleviates high glucose-induced inhibition of osteoblast differentiation by modulating PI3K/AKT/GSK3β/β-catenin pathway.
Insights
Runx2 protein can counteract high glucose effects on bone cells, promoting osteoblast differentiation and matrix mineralization. This pathway involves PI3K/AKT/GSK3β/β-catenin signaling, offering potential therapeutic targets for diabetic bone disease.
Area of Science:
- Biomedical Science
- Cell Biology
- Endocrinology
Background:
- Diabetic osteopathy is linked to hyperglycemia, impacting bone health.
- Runx2 is crucial for osteogenic differentiation, but its role in high-glucose conditions needs clarification.
- Rat bone mesenchymal stem cells (rBMSCs) are a relevant model for studying bone cell differentiation.
Purpose of the Study:
- To investigate the effect of Runx2 on osteoblast differentiation in high-glucose conditions using rBMSCs.
- To elucidate the signaling pathway involved in Runx2-mediated osteogenesis under hyperglycemia.
- To assess the impact of high glucose and Runx2 on key osteogenic markers and mineralization.
Main Methods:
- Evaluated osteogenic differentiation markers (Runx2, ALP, OC, OPN) and mineralization (ALP staining, Alizarin red S).
- Utilized Western blot to analyze PI3K/AKT/GSK3β/β-catenin pathway proteins.
- Performed immunofluorescence staining to determine β-catenin subcellular localization.
Main Results:
- High glucose significantly inhibited osteogenic differentiation, while hyperosmolarity did not.
- Runx2 upregulated osteogenic gene expression and enhanced matrix mineralization.
- Inhibition of PI3K/AKT pathway with LY294002 abolished the beneficial effects of Runx2.
Conclusions:
- Runx2 alleviates high glucose-induced inhibition of osteoblast differentiation.
- The protective effect of Runx2 is mediated through the PI3K/AKT/GSK3β/β-catenin signaling pathway.
- Targeting this pathway may offer therapeutic strategies for diabetic bone complications.
More Related Videos
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
Cell Specific Gene Expression